Device Dossier
Immunohistology cell marker IVDs
Device Dossier for Immunohistology cell marker IVDs (CT1056 - Immunohistology cell marker IVDs, Class 3, sponsor Agilent Technologies). ARTG record,…
- GMDN category: CT1056 - Immunohistology cell marker IVDs
Intended purpose
HercepTest™ is a semi-quantitative immunocytochemical assay to determine HER2 protein overexpression in breast cancer tissues routinely processed for histological evaluation and formalin-fixed, paraffin-embedded cancer tissue from patients with adenocarcinoma of the stomach including gastroesophageal junction. HercepTest™ is indicated as an aid in the assessment of patients for whom Herceptin™ (trastuzumab) treatment is being considered (see Herceptin™ package insert).